Harrow Health
HROWHarrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company (NASDAQ: HROW) based in Nashville, TN. The change of name to Harrow Health in January 2019 reflected a goal of "creating, investing in, operating and growing a diversified portfolio of health care …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Harrow Health
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/24/2024 | Buy | Opaleye Management Inc. | Ten Percent Owner | $10.2 | $84,093 |
| 4/23/2024 | Buy | Opaleye Management Inc. | Ten Percent Owner | $10.3 | $120,547 |
| 4/19/2024 | Buy | Opaleye Management Inc. | Ten Percent Owner | $10.6 | $310,391 |
| 3/28/2024 | Buy | Opaleye Management Inc. | Ten Percent Owner | $12.8 | $641,000 |
| 3/22/2024 | Buy | Baum, Mark L. | CHIEF EXECUTIVE OFFICER | $11.6 | $104,310 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)